0
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Life and Death in the Microcirculation: a Role for Angiotensin II

Pages 101-107 | Published online: 10 Jul 2009

References

  • Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M. (1993). PDGF-BB modulates endothelial prolif-eration and angiogenesis in vitro via PDGF (3-receptors. J Cell Biol 125:917–928.
  • Benter IF, Diz DI, Ferrario CM. (1993). Cardiovas-cular actions of angiotensin (1–7). Peptides 14:679–684.
  • Boegehold MA, Johson MD, Overbeck HW. (1991). Pressure independent arteriolar rarefaction in hyper-tension. Am J Physiol 261:H83–H87.
  • Brechler V, Jones PW, Levens NR, de Gasparo M, Bottari S. (1993). Agonistic and antagonistic proper-ties of angiotensin analogs at the AT2 receptor in PC12W cells. Regul Peptides 44:207–213.
  • Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner PD. (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exer-cise. J Appl Physiol 81:355–361.
  • Brosnihan KB, Li P, Ferrario CM. (1996). Angioten-sin (1–7) dilates canine coronary arteries through ki-nins and nitric oxide. Hypertension 27\(part 2):523–528.
  • Chen IIH, Prewitt RL, Dowell RF. (1981). Microvas-cular rarefaction in spontaneously hypertensive rat cremaster muscle. Am J Physiol 241:H306–H310.
  • Chua CC, Diglio CA, Siu BB, Chua BH. (1994). An-giotensin II induces TGF-beta 1 production in rat heart endothelial cells. Biochim Biophys Acta 1223(1):141–147.
  • Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. (1991). Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arte-rial wall. Circ Res 68:450–456.
  • de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PB. (1995). Proposed update of angio-tensin receptor nomenclature. Hypertension 25:924–927.
  • Dzau VJ. (1993). Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 22(Suppl 5):S1–59.
  • Gibbons GH. (1995). Vascular remodeling in hyper-tension: role of autocrine-paracrine factors. Blood Pressure Suppl 2:49–54.
  • Greene AS, Lombard JH, Cowley AW Jr, Hansen-Smith FM. (1990). Microvessel changes in hyperten-sion measured by Griffonia simplicifolia I Lectin. Hy-pertension 15:779–783.
  • Greene AS, Tonellato PJ, Lui J, Lombard JH, Cowley AW Jr. (1989). Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol (Heart Circ Physiol):H/26–H131.
  • Greene AS, Tonellato PJ, Zang Z, Lombard JH, Cow-ley AW Jr. (1992). Effect of microvascular rarefac-tion on tissue oxygen delivery in hypertension. Am J Physiol 262 (Heart Circ Physiol 31 ) : H1486–H1493.
  • Haberl RL, Anneser F, Villringer A, EinhaTupl KM. (1990). Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am J Physiol 258:H1840–H1846.
  • Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW. (1995). Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Peptides 58: 107–115.
  • Hansen-Smith FM, Greene AS, Cowley AW, Lombard JH. (1990). Structural changes during microvascular rarefaction in chronic hypertension. Hypertension /5(6 Pt. 2):922–928.
  • Hansen-Smith FM, Morris LW, Greene AS, Lombard JH. (1996). Rapid microvessel rarefaction with el-evated salt intake and reduced renal mass hyperten-sion in rats. Circ Res 79:324–330.
  • Hernandez I, Cowley AW Jr, Lombard JH, Greene AS. (1992). Salt intake and angiotensin II alter mi-crovessel density in the cremaster muscle of normal rats. Am J Physiol 263 (Heart Circ Physiol 32): H664–H667.
  • Hernandez I, Greene AS. (1995). Hemodynamic and microcirculatory changes during development of re-nal hypertension. Am J Physiol 268 (Heart Circ Physiol):H33–H38.
  • Hutchins PM, Darnell AE. (1974). Observation of a decreased number of small arterioles in spontane-ously hypertensive rats. Circ Res (Suppl 1):161–165.
  • Kanagy NL, Fink GD. (1993). Losartan prevents salt-induced hypertension in reduced renal mass rats. J Pharmacol Exp Ther 265:1131–1136.
  • Kerins DM, Hao Q, Vaughan DE. Angiotensin induc-tion of PAI-1 expression in endothelial cells is medi-ated by the hexapeptide angiotensin IV. J Clin Invest 96:2515-2520.
  • Lever AF.. (1993). Slow developing pressor effect of angiotensin II and vascular structure. J Hypertension 11(suppl):527–528.
  • Lombard JH, Hinojosa-Laborde C, Cowley AW Jr. (1989). Hemodynamics and microcirculatory alter-ations in reduced renal mass hypertension. Hyperten-sion13:128–138.
  • Luque M, Martin P, Martell N, Fernandez C, Brosni-han KB, Ferrario CM. (1996). Effects of captopril related to increased levels of prostacyclin and angio-tensin (1–7) in essential hypertension. J Hypertension 14:799–805.
  • Munzenmaier DH, Greene AS. (1996). Opposing ac-tions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27:760–765.
  • Munzenmaier DH, Greene AS. (1995). Angiotensin II receptor subtypes mediate opposing actions in the control of blood pressure and vascular tone. Hyper-tension26:579.
  • Munzenmaier DH, Greene AS. (1995). Angiotensin II mediates a sustained rise in nuclear and cytoplasmic calcium via multiple receptor subtypes. Am J Physiol 269 (2, pt. 2):H565–H570.
  • Munzenmaier DH, Greene AS. (1994). Stimulation of soluble guanylate cyclase activity by angiotensin II is mediated by a non-AT1 receptor mechanism in rat aorta. FASEB J 8:A367.
  • Papanek PE, Rieder MJ, Greene AS. (1996). Capto-pril blocks angiogenic response to short-term exer-cise. Microcirculation 3:100.
  • Rieder MJ, Alkayed NJ, Harder DR, Roman RJ, Greene AS. (1995). Molecular cloning of angiotensin II type 2 receptor (AT2) from rat cerebral microves-s el s.FASEB J9:A24.
  • Rieder MJ, Roman RJ, Greene AS. (1997). Reversal of microvascular rarefaction and reduced renal mass hy-pertension. Hypertension 30:120–127.
  • Simon G, Altman S. (1992). Subpressor angiotensin II is a bifunctional growth factor of vascular muscle in rat s.JHypertension10:1165–1171.
  • Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. (1995). The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95:651–657.
  • Viswanathan M, Saavedra JM. (1992). Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing.Peptides13:783–786.
  • Wang DH, Prewitt RL, Beebe SJ. (1995). Regulation of PDGF-A: a possible mechanism for angiotensin II-induced vascular growth. Am J Physiol 269(1 Pt 2): H356–H364.
  • Wang DH, Prewitt RE. (1990). Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 15:68–77.
  • Wong PC, Hart SD, Chiu AT, Herblin WF, Carini DJ, Smith RD, Wexler RR, Timmermans PB. (1991). Pharmacology of DuP 532, a selective and noncom-petitive AT1 receptor antagonist. J Pharmacol Exp Ther 259:861–870.
  • Yamada T, Horiuchi M, Dzau V. Angiotensin II type 2 receptor mediates programmed cell death. Proc Nall Acad Sci USA93:156–160.
  • Ylitalo P. Hepp R, Mohring J, Gross F. (1976). Ef-fects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrecto-mized rats. J Lab Clin Med 88:807–816.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.